Flash Finance

Neogen Chemicals LimitedNEOGENCorporate

Chemicals Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹2,484.80
MCap ₹7,465 Cr · P/E 209.9
Neogen Chemicals Limited — Stock analysis & AI research Neogen Chemicals Limited — Multibagger AI analysis Neogen Chemicals Limited — Seasonality — best & worst months Neogen Chemicals Limited — Technical indicators & charts Neogen Chemicals Limited — Technical setup — score, trend, support & resistance Neogen Chemicals Limited — Live exchange announcements
📋 Stocks With Strong Quarterly Results📋 Promoters Increasing Stake 📈 MACD Bullish Crossover📈 Strong Trend Stocks (ADX > 25)📈 Bollinger Squeeze Stocks📈 Bullish EMA Alignment📈 Relative Strength Leaders📈 Multi-Timeframe Bullish Stocks 🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹250 Cr
Sales · Jun 2026
+34.0% YoY
₹48 Cr
Operating Profit · Jun 2026
+53.1% YoY
19.3%
OPM % · Jun 2026
+14.2% YoY
₹17 Cr
Net Profit · Jun 2026
+66.8% YoY
₹6.29
EPS · Jun 2026
+61.7% YoY

📝 Neogen Chemicals Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Neogen Chemicals Limited reported revenue of ₹250 crore for the quarter ended June 2026 (Q1 FY27), up 34.0% from ₹187 crore in the same quarter last year, and up 1.5% sequentially over the March 2026 quarter.

Net profit rose 66.8% year-on-year to ₹17 crore, from ₹10 crore. Earnings per share (EPS) came in at ₹6.29.

Operating profit stood at ₹48 crore — an operating margin (OPM) of 19.3%, compared with 16.9% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Neogen Chemicals Limited posted revenue of ₹862 crore, a growth of 10.9% over FY25, with a net profit of ₹29 crore (down 17.6% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹926 crore with a net profit of ₹36 crore.

Valuation snapshot

At the current price of ₹2,484.80, NEOGEN has a market capitalisation of ₹7,465 crore and a trailing P/E of about 209.9.

Within the Chemicals industry, it is the 11th-largest of the 79 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 53.01%, foreign institutional investors (FIIs) 3.87%, domestic institutional investors (DIIs) 17.08%, public shareholders 26.05% of Neogen Chemicals Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹7,465 Cr
Current Price ?
₹2,484.8
P/E ?
209.93above ind
Industry P/E ?
24.60
P/B ?
9.15
P/S ?
8.07
P/FCF ?
-11.54
Enterprise Value ?
₹8,860 Cr
EV/EBITDA ?
57.53
PEG ?
N/A
Earnings Yield ?
1.4%
Dividend Yield ?
0.04%
Profitability & Returns
Sales (TTM) ?
₹926 Cr
OPM ?
16.6%
Profit after tax (TTM) ?
₹36 Cr
EPS (TTM) ?
₹11.84
ROCE ?
6.0%
ROE ?
4.4%
ROA ?
1.2%
Growth
Sales — latest qtr ?
₹250 Cr
PAT — latest qtr ?
₹17 Cr
YoY qtr sales growth ?
34.0%
YoY qtr profit growth ?
66.8%
Sales growth (3y) ?
8%
Sales growth (5y) ?
21%
Profit growth (3y) ?
-17%
Profit growth (5y) ?
-2%
Financial Health
Debt ?
₹1,395 Cr
Debt to Equity ?
1.71
Interest Coverage ?
1.5
Current Ratio ?
N/A
Ownership
Promoter holding ?
53.01%
Change in promoter holding ?
1.79%
Pledged percentage ?
N/A
Market
Return 3 months ?
14.2%
Return 6 months ?
64.4%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 204165168164200180193201203187209220247250 +34.0% +1.5%
Operating Profit 3328262036313535363230324448 +53.1% +9.8%
Other Income 22222211112214 +230.1% +314.3%
Interest 911111110101313121319222121 +64.2% -3.1%
Depreciation 45566777767788 +41.9% +7.9%
Profit Before Tax 211412622161515414561623 +62.9% +46.9%
Net Profit 14109117111110210341117 +66.8% +50.2%
EPS 5.743.923.660.416.424.354.153.800.913.891.281.404.326.29 +61.7% +45.6%
OPM % 16.0% 17.0% 15.6% 12.3% 18.0% 17.1% 17.8% 17.2% 17.9% 16.9% 14.4% 14.5% 17.8% 19.3% +14.2% +8.4%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹778 Cr ₹862 Cr ₹926 Cr +10.9%
Operating Profit ₹136 Cr ₹137 Cr ₹154 Cr +0.7%
OPM % 17.53% 15.93% 16.64% -9.1%
NPM % 4.48% 3.33% 3.84% -25.7%
Other Income ₹4 Cr ₹6 Cr ₹9 Cr +55.2%
Depreciation ₹28 Cr ₹28 Cr ₹30 Cr -1.0%
Interest ₹48 Cr ₹75 Cr ₹83 Cr +54.9%
EBIT ₹109 Cr ₹110 Cr ₹124 Cr +1.1%
PBT ₹50 Cr ₹41 Cr ₹50 Cr -18.2%
Tax ₹15 Cr ₹12 Cr ₹15 Cr -18.7%
Net Profit ₹35 Cr ₹29 Cr ₹36 Cr -17.6%
EPS ₹13.21 ₹10.89 ₹13.29 -17.6%
Material Cost ₹506 Cr ₹638 Cr ₹690 Cr +26.1%
Employee Cost ₹65 Cr ₹90 Cr ₹96 Cr +38.9%
Extraordinary Items ₹14 Cr — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
CWIP 36109156857 +449.4%
Equity Capital 25262626 +0.0%
Reserves 458734763790 +3.5%
Borrowings 3704095971,395 +133.7%
Other Liabilities 202292361691 +91.4%
Total Liabilities 1,0541,4611,7472,902 +66.1%
Fixed Assets 347496404475 +17.6%
Investments 77000 —
Other Assets 5948561,1871,570 +32.3%
Total Assets 1,0541,4611,7472,902 +66.1%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -30-29196-231 -217.9%
Cash from Investing Activity -94-216-317-410 -29.3%
Cash from Financing Activity 100237113642 +468.1%
Net Cash Flow -25-8-8-0 +100.0%
Free Cash Flow -134-332-121-647 -434.7%
CFO/OP -17%-18%153%-154% -200.7%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 9414994161 +71.3%
Inventory Days 275365267445 +66.7%
Days Payable 147138227346 +52.4%
Cash Conversion Cycle 223376134260 +94.0%
Working Capital Days 7912912385 -30.9%
ROCE % 13%9%9%6% -33.3%

👥 Shareholding (latest 6 periods)

Metric Sep 2025Dec 2025Mar 2026Apr 2026Jun 2026Sep 2026 % Chg
Promoters 51.22%51.22%51.22%53.00%53.01%53.01% +0.0%
FIIs 5.15%4.57%4.46%4.29%4.11%3.87% -5.8%
DIIs 25.22%21.99%22.65%21.67%19.60%17.08% -12.9%
Public 18.40%22.21%21.67%21.05%23.28%26.05% +11.9%
No. of Shareholders 45,71047,88454,33256,33061,98868,402 +10.3%

⚖️ Peer comparison

Industry: Chemicals · top 25 of 79 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 NAVINFLUOR Navin Fluorine ₹8,545.00 43,843 55.4 3,634 790 33.9% 21.7% 41.1% 130.1% 44.1% 107.7%
2 DEEPAKNTR Deepak Nitrite ₹1,596.00 21,768 27.8 8,575 784 15.5% 9.1% -4.8% -22.5% 36.4% 207.4%
3 DEEPAKFERT Deepak Fertilisers ₹1,323.00 16,718 17.0 12,103 985 16.7% 8.1% 12.0% -21.8% 22.5% 101.0%
4 TATACHEM Tata Chemicals ₹615.00 15,668 — 15,120 -1,971 11.3% -13.0% -2.0% -543.2% 14.4% -81.0%
5 PCBL PCBL Chemical ₹331.50 13,043 43.3 6,596 298 13.4% 4.5% -12.5% -46.0% 17.0% 64.8%
6 JUBLINGREA Jubilant Ingrevia ₹647.25 10,208 33.3 4,651 308 13.4% 6.6% 5.1% 10.3% 25.3% 40.9%
7 ALKYLAMINE Alkyl Amines ₹1,818.60 9,301 41.3 1,658 225 20.6% 13.5% -2.3% -3.8% 30.1% 93.1%
8 CLEAN Clean Science ₹820.00 8,715 37.4 982 232 35.7% 23.6% -2.5% -13.7% 21.9% -4.7%
9 GNFC Gujarat Narmada ₹539.75 7,931 7.6 8,410 1,037 14.8% 12.3% -1.5% 35.3% 39.8% 275.9%
10 GALAXYSURF Galaxy Surfactants ₹2,156.30 7,887 21.6 5,752 353 10.4% 6.1% 24.3% -50.0% 39.4% 108.7%
11 NEOGEN Neogen Chemicals ₹2,403.50 7,221 180.9 926 36 16.6% 3.8% 10.9% -17.6% 34.0% 66.8%
12 BALAMINES Balaji Amines ₹2,215.00 7,177 35.3 1,523 211 21.4% 13.9% 2.0% 6.5% 27.2% 113.9%
13 FCL Fineotex Chemical ₹53.07 6,180 41.6 1,012 148 16.7% 14.6% 44.8% 14.5% 174.8% 92.6%
14 ACI Archean Chemical ₹470.90 5,814 61.0 1,123 95 20.3% 8.5% 7.8% -37.0% 8.9% -24.4%
15 GULFOILLUB Gulf Oil ₹1,057.20 5,235 13.9 4,367 371 12.6% 8.5% 11.7% -3.4% 30.6% 27.0%
16 FOSECOIND Foseco India ₹6,846.50 5,186 64.7 618 77 17.5% 12.5% 12.2% -1.9% 9.2% 8.9%
17 GUJALKALI Gujarat Alkalies ₹696.50 5,115 77.0 4,497 66 11.2% 1.5% 7.0% 96.3% 12.6% 499.0%
18 LXCHEM Laxmi Organic ₹178.50 4,961 40.2 3,117 123 8.2% 4.0% -4.7% -43.4% 44.1% 194.8%
19 VISHNU Vishnu Chemicals ₹724.90 4,880 32.6 1,694 150 15.5% 8.8% 11.1% 12.2% 24.9% 23.0%
20 YASHO Yasho Industries ₹4,028.70 4,857 84.9 939 57 19.5% 6.1% 24.0% 771.1% 54.9% 801.3%
21 EPIGRAL Epigral ₹1,084.00 4,677 17.3 2,626 271 22.2% 10.3% -0.9% -7.2% 16.3% -37.9%
22 TATVA Tatva Chintan ₹1,867.60 4,369 85.0 556 51 19.3% 9.2% 32.6% 702.6% 42.8% 128.3%
23 GHCL GHCL ₹418.85 3,839 7.4 3,043 525 23.0% 17.3% -3.7% -23.5% -2.7% 31.8%
24 PREMEXPLN Premier Explosives ₹685.10 3,685 110.0 349 34 6.8% 9.6% -7.0% 60.5% -27.8% -80.2%
25 GRAUWEIL Grauer & Weil ₹76.61 3,474 21.2 1,190 165 16.2% 13.9% 5.8% 11.0% 4.4% 92.3%
❓ Frequently asked questions
What was Neogen Chemicals Limited's revenue in Q1 FY27?
Neogen Chemicals Limited reported revenue of ₹250 crore for the quarter ended June 2026 (Q1 FY27), up 34.0% from ₹187 crore in the same quarter last year, and up 1.5% sequentially over the March 2026 quarter.
What was Neogen Chemicals Limited's net profit in Q1 FY27?
Net profit rose 66.8% year-on-year to ₹17 crore, from ₹10 crore. Earnings per share (EPS) came in at ₹6.29.
What is NEOGEN's market capitalisation and P/E ratio?
At the current price of ₹2,484.80, NEOGEN has a market capitalisation of ₹7,465 crore and a trailing P/E of about 209.9.
Who owns Neogen Chemicals Limited? (shareholding pattern)
As of Sep 2026, promoters held 53.01%, foreign institutional investors (FIIs) 3.87%, domestic institutional investors (DIIs) 17.08%, public shareholders 26.05% of Neogen Chemicals Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI